AARDVARK THERAPEUTICS INC

Sun Nelson’s recent sale of 14,754 Aardvark shares shows disciplined insider trading amid a 4‑month decline and soaring social‑media buzz – a routine move that signals a shift toward conservative capital allocation, not a warning of failure.

Inside Aardvark Therapeutics: insiders buy 44,964 options, signaling confidence amid volatility and a hopeful rebound as the company re‑prices its plans.

Sun Nelson’s recent sale of 70,549 unvested Aardvark options signals confidence in the stock’s near‑term rally, offering investors insight into insider strategy and potential stability ahead of the HERO trial approval.